Surgery Partners (SGRY) Change in Receivables (2014 - 2026)

Surgery Partners' Change in Receivables history runs 13 years deep, the most recent figure standing at -$3.6 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 25.0% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at $55.0 million (down 24.35% YoY), while the FY2025 annual figure was $53.8 million, down 25.38% from the prior year.
• Change in Receivables came in at -$3.6 million for Q1 2026 at Surgery Partners, down from $46.1 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $46.1 million in Q4 2025 to a low of -$8.8 million in Q1 2023.
• A 5-year average of $12.0 million and a median of $13.1 million in 2023 frame the typical range for Change in Receivables.
• On a YoY basis, Change in Receivables climbed as much as 555.0% in 2023 and fell as far as 340.0% in 2023.
• Surgery Partners' Change in Receivables stood at $38.7 million in 2022, then declined by 25.06% to $29.0 million in 2023, then surged by 41.03% to $40.9 million in 2024, then rose by 12.71% to $46.1 million in 2025, then plunged by 107.81% to -$3.6 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$3.6 million, $46.1 million, and $16.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison